Enhancement of Brain Circuit of Inhibitory Control in Obese Patients Undergoing Gastric Banding (Neuroband)
Neuroband: The Effect of Perioperative Enhancement of the Brain Circuit of Inhibitory Control in Obese Patients Undergoing Laparoscopic Adjustable Gastric Banding (LAGB)
Sponsor: Beth Israel Deaconess Medical Center
A NA clinical study on Obesity, this trial is completed. The trial is conducted by Beth Israel Deaconess Medical Center and has accumulated 9 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Feb 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 4 earlier versions
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Sep 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
Phase: PHASE2 → NA
-
Jan 2017 — Sep 2017 [monthly]
Active Not Recruiting PHASE2
First recorded
Jun 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beth Israel Deaconess Medical Center
- Boston Medical Center
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
For direct contact, visit the study record on ClinicalTrials.gov .